SAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

The project has four roving clinics that influencers are contracted to visit to brand HIV prevention as hip and ‘cool’ ...

The results of a groundbreaking trial carried out in Durban to find a cure for HIV are showing promise, scientists say.

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...